Apexian Pharmaceuticals
2 known investors
Find your way into Apexian Pharmaceuticals
Sign up to see every warm intro you have to Apexian Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Apexian Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Apexian Pharma is a biopharmaceutical company developing APX3330, an oral drug for treating Inflammatory Bowel Disease, including Crohn's disease and ulcerative colitis, as a single agent or in combination. It targets upstream modulation of inflammation for IBD patients who fail to achieve durable remission on current therapies.
Investors · 2
Elevate Ventureslisted by Elevate VenturesIndianapolis · $20K – $2M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Apexian Pharmaceuticals do?
- Apexian Pharma is a biopharmaceutical company developing APX3330, an oral drug for treating Inflammatory Bowel Disease, including Crohn's disease and ulcerative colitis, as a single agent or in combination. It targets upstream modulation of inflammation for IBD patients who fail to achieve durable remission on current therapies.
- Who are Apexian Pharmaceuticals's investors?
- Apexian Pharmaceuticals's investors include Elevate Ventures, IU Ventures.